发明名称 Anti B7-H3 antibody
摘要 An antibody exhibiting antitumor activity that binds to B7-H3, a functional fragment of the antibody, a pharmaceutical composition that includes the antibody or the functional fragment, methods for making the antibody or the functional fragment, methods for treating a tumor using the antibody or the functional fragment, and polynucleotides encoding the antibody or the functional fragment.
申请公布号 US9371395(B2) 申请公布日期 2016.06.21
申请号 US201213455021 申请日期 2012.04.24
申请人 Daiichi Sankyo Company, Limited 发明人 Takahashi Shu;Matsuoka Tatsuji;Murakami Kenji;Takizawa Takeshi;Hirotani Kenji;Urano Atsushi;Fukuchi Keisuke;Yazawa Mitsuhiro
分类号 C12P21/08;C07K16/00;C07K16/30;C07K16/28;A61K39/395;C07H21/00;C07K16/42 主分类号 C12P21/08
代理机构 Christensen O'Connor Johnson Kindness PLLC 代理人 Christensen O'Connor Johnson Kindness PLLC
主权项 1. An antibody characterized by having the following properties: (a) specific binding to an IgC1 and/or IgC2 domain of B7-H3, (b) having a constant region that is a human constant region; (c) comprising CDRH1 consisting of an amino acid sequence comprising SEQ ID NO: 92, CDRH2 consisting of an amino acid sequence comprising SEQ ID NO: 93, and CDRH3 consisting of an amino acid sequence comprising SEQ ID NO: 94 as complementarity determining regions of the heavy chain and comprising CDRL1 consisting of an amino acid sequence comprising SEQ ID NO: 95, CDRL2 consisting of an amino acid sequence comprising SEQ ID NO: 96, and CDRL3 consisting of an amino acid sequence comprising SEQ ID NO: 97 as complementarity determining regions of the light chain; (d) having an antibody-dependent cell-mediated phagocytosis (ADCP) activity; and (e) having an in vivo antitumor activity against tumors expressing B7-H3 comprising SEQ ID NO: 6 or SEQ ID NO:10.
地址 Tokyo JP